Intuitive Surgical, Inc. ISRG

405.18 5.66 1.42% as of 25 Sep
Market cap
$140.7B
P/E
45.8×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Intuitive Surgical, Inc. (ISRG) EV/Sales

As of 25 September 2026, Intuitive Surgical, Inc. (ISRG) trades at a EV/Sales of 12.5×. Over the past ten years it has ranged from 6.6× (October 2015) to 25.5× (January 2025); the current reading is higher than 30% of that period. That is above the Medical Instruments & Supplies industry median of 3.1× and above the Healthcare sector median of 3.6×.

EV/Sales, daily

Annual

Period EV/Sales Change
FY2025 19.5× (10.24%)
FY2024 21.7× 39.36%
FY2023 15.6× 7.30%
FY2022 14.5× (32.98%)
FY2021 21.7× 4.21%
FY2020 20.8× 43.29%
FY2019 14.5× 5.18%
FY2018 13.8× 8.39%
FY2017 12.7× 56.44%
FY2016 8.1× 3.76%

Quarterly

Period EV/Sales Change
Jun 2026 12.3× (18.26%)
Mar 2026 15.0× (22.88%)
Dec 2025 19.5× 21.22%
Sep 2025 16.1× (22.39%)
42 more quarters

Against its own ten years

Low 6.6× High 25.5×
Ten-year median 14.7×
Current reading's percentile 30

EV/Sales against peers

Company EV/Sales
MDLN Medline Inc. compare 1.3×
BAX Baxter International Inc. compare 1.7×
SOLV Solventum Corporation compare 2.4×
BDX Becton, Dickinson and Company compare 2.8×
ALC Alcon compare 3.2×
RMD ResMed Inc. compare 5.5×
WST West Pharmaceutical Services, Inc. compare 7.8×
ISRG Intuitive Surgical, Inc. 12.5×
RGEN Repligen Corporation compare 13.4×
Medical Instruments & Supplies industry median 3.1×
Healthcare sector median 3.6×
Market median 2.2×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on ISRG